ES8207142A1 - Procedimiento para preparar derivados de piridoxina - Google Patents

Procedimiento para preparar derivados de piridoxina

Info

Publication number
ES8207142A1
ES8207142A1 ES506375A ES506375A ES8207142A1 ES 8207142 A1 ES8207142 A1 ES 8207142A1 ES 506375 A ES506375 A ES 506375A ES 506375 A ES506375 A ES 506375A ES 8207142 A1 ES8207142 A1 ES 8207142A1
Authority
ES
Spain
Prior art keywords
preparation
pyridoxine
piridoxine
derivatives
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES506375A
Other languages
English (en)
Other versions
ES506375A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
D&D SRL
Original Assignee
D&D SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by D&D SRL filed Critical D&D SRL
Publication of ES506375A0 publication Critical patent/ES506375A0/es
Publication of ES8207142A1 publication Critical patent/ES8207142A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/281-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/672-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE PIRIDOXINA DE FORMULA (I), EN LA QUE R1 ES EL RESTO DE UNO DE VARIOS ACIDOS. CONSISTE EN LA REACCION DE IOSPROPOLINEN-PIRIDOXINA CON EL HALURO DEL ACIDO, EN PRESENCIA DE UNA BASE COMO ACEPTOR DE ACIDO, TAL COMO UNA AMINA TERCIARIA, SEGUIDA DE LA HIDROLISIS DEL ESTER FORMADO, MEDIANTE CALENTAMIENTO A REFLUJO DE ESTE HIDROALCOHOLICO CONSTITUIDO POR AGUA Y UN ALCOHOL ALIFATICO INFERIOR EN LA RELACION DE 1:2 A 1:5. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SUS PROPIEDADES ANTIINFLAMATORIAS, ANTIFLOGISTICAS Y ANALGESICAS.
ES506375A 1980-10-21 1981-10-20 Procedimiento para preparar derivados de piridoxina Expired ES8207142A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT25473/80A IT1133963B (it) 1980-10-21 1980-10-21 Derivati piridossinici ad attivita' terapeutica,procedimento per la loro preparazione e relative composizioni farmaceutiche

Publications (2)

Publication Number Publication Date
ES506375A0 ES506375A0 (es) 1982-09-01
ES8207142A1 true ES8207142A1 (es) 1982-09-01

Family

ID=11216796

Family Applications (1)

Application Number Title Priority Date Filing Date
ES506375A Expired ES8207142A1 (es) 1980-10-21 1981-10-20 Procedimiento para preparar derivados de piridoxina

Country Status (17)

Country Link
US (1) US4412996A (es)
EP (1) EP0050385B1 (es)
JP (1) JPS5795962A (es)
AR (1) AR230747A1 (es)
AT (1) ATE17850T1 (es)
AU (1) AU551422B2 (es)
BE (1) BE890798A (es)
CA (1) CA1190922A (es)
DE (1) DE3173724D1 (es)
DK (1) DK462181A (es)
ES (1) ES8207142A1 (es)
FR (1) FR2492375B1 (es)
IT (1) IT1133963B (es)
MX (1) MX154715A (es)
NO (1) NO159855C (es)
PT (1) PT73844B (es)
YU (1) YU42439B (es)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3717636A (en) * 1970-01-21 1973-02-20 A Esanu Salts of pyridoxine mono-esters
ES411535A1 (es) * 1973-02-12 1976-01-01 Farmabion S A Un procedimiento para la preparacion de esteres del 1-(p- cloro-benzoil)-5-metoxi-2 metilindol-3-acetico, con feno- les.
SE428560B (sv) * 1974-07-22 1983-07-11 Merck & Co Inc Forfarande for framstellning av 5-(2,4-difluorofenyl)salicylsyra.
JPS52156862A (en) * 1976-06-22 1977-12-27 Hisamitsu Pharmaceut Co Inc Novel indoleacetic acid ester derivatives
CH601228A5 (en) * 1977-06-17 1978-06-30 Hisamitsu Pharmaceutical Co Antiinflammatory indomethacin esters active topically and orally
IT1097601B (it) * 1978-07-31 1985-08-31 Crinos Industria Farmaco Derivati della piridosina ad attivita' farmacologica
US4233304A (en) * 1978-07-31 1980-11-11 Crinos Industria Farmacobiologica S.P.A. Pyridoxine derivatives

Also Published As

Publication number Publication date
US4412996A (en) 1983-11-01
JPS5795962A (en) 1982-06-15
AU551422B2 (en) 1986-05-01
YU251981A (en) 1984-02-29
NO159855B (no) 1988-11-07
AR230747A1 (es) 1984-06-29
IT1133963B (it) 1986-07-24
IT8025473A0 (it) 1980-10-21
CA1190922A (en) 1985-07-23
EP0050385A1 (en) 1982-04-28
FR2492375A1 (fr) 1982-04-23
ES506375A0 (es) 1982-09-01
MX154715A (es) 1987-12-03
EP0050385B1 (en) 1986-02-05
ATE17850T1 (de) 1986-02-15
BE890798A (fr) 1982-02-15
FR2492375B1 (fr) 1986-10-10
JPH0343268B2 (es) 1991-07-01
AU7662281A (en) 1982-09-09
YU42439B (en) 1988-08-31
DK462181A (da) 1982-04-22
PT73844A (en) 1981-11-01
DE3173724D1 (en) 1986-03-20
PT73844B (en) 1983-01-25
NO813537L (no) 1982-04-22
NO159855C (no) 1989-02-15

Similar Documents

Publication Publication Date Title
JPS57122049A (en) 1,1,2-triphenylbutene-1 derivative and therapeutically soluble salt, manufacture and medicine
AU591351B2 (en) 1,5-diphenylpyrazole-3-carboxylic acid derivatives for the protection of cultivated plants
AU521560B2 (en) Acid hydrolysis of cellulose to yield glucose
ES8702427A1 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
ES480721A1 (es) Un procedimiento para aislar pseudomonato de litio.
ES8400417A1 (es) "procedimiento para la preparacion de esteres carboxilicos de 6-hidroxi-2-benzotiazolsulfonamida".
HU9303009D0 (en) New 2-saccharinyl-methyl-aryl-carboxylat derivatives and pharmaceutical preparations containing said compounds
ES8207142A1 (es) Procedimiento para preparar derivados de piridoxina
IL61261A (en) Pyridine and pyrimidine derivatives and pharmaceutical compositions containing them
ES8104222A1 (es) Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo (3,2,0) hept-2-en-2-carboxilico
IL99203A0 (en) Process for the preparation of aminomethylphosphonic acid and aminomethylphosphinic acids
JPS57154192A (en) Bis-esters of alkanediol as antibacterial
ATE9584T1 (de) Antibakterielle beta-lactam-verbindungen, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
GB1319772A (en) Succinimides
FR2369288A1 (fr) Procede de preparation de composes organiques d'etain
ES8201531A1 (es) Procedimiento de preparar alcoxi propanolaminas
ES8202341A1 (es) Un procedimiento para preparar derivados de la ergolin.
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
OA05991A (fr) Procédé de préparation d'une composition active contre la drépanocytose.
IL65664A (en) 5-(4-phenyl-1-piperidinyl)methyl-2,3-dihydro-2-oxo-1h-imidazole-4-carboxylic acid derivatives and process for their preparation
AU550441B2 (en) 3-chloro-pregnane and preparation
DE3572171D1 (en) Theophylline-7-acetic acid ester of d,l-trans-sobrerol having mucosecretolytic-fluidizing and antibronchospastic activity, a process for its preparation and pharmaceutical compositions thereof
JPS55145669A (en) 8,10-diazaprostanoic acid derivative and its preparation
ES8206476A1 (es) Procedimiento de preparacion de derivados de piperidina
ES8205788A1 (es) Procedimiento de preparar derivados del acido nicotinico

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990503